Racial difference in sarcoidosis mortality in the United States.
about
Annexins family: insights into their functions and potential role in pathogenesis of sarcoidosisAssociation Between Occupational Exposures and Sarcoidosis: An Analysis From Death Certificates in the United States, 1988-1999Moving toward true inclusion of racial/ethnic minorities in federally funded studies. A key step for achieving respiratory health equality in the United States.Sarcoidosis in the national veteran population: association of ocular inflammation and mortalityCumulative Incidence and Predictors of Progression in Corticosteroid-Naïve Patients with Sarcoidosis.In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012.Epidemiology of Sarcoidosis 1946-2013: A Population-Based Study.Association of Neutrophil to Lymphocyte Ratio and Pulmonary Hypertension in Sarcoidosis Patients.The Diagnosis, Differential Diagnosis, and Treatment of SarcoidosisSarcoidosis Increases Risk of Hospitalized Infection. A Population-based Study, 1976-2013.A Circulating Micro-RNA Signature Serves as a Diagnostic and Prognostic Indicator in Sarcoidosis.Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota.Refractory pulmonary sarcoidosis - proposal of a definition and recommendations for the diagnostic and therapeutic approach.Hospitalization Among Patients with Sarcoidosis: A Population-Based Cohort Study 1987-2015.From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis.Sarcoidosis in America. Analysis Based on Health Care Use.Granulomatosis with polyangiitis according to geographic origin and ethnicity: clinical-biological presentation and outcome in a French population.Evidence of selection as a cause for racial disparities in fibroproliferative disease.Reliability of Cardiovascular Risk Calculators to Estimate Accurately the Risk of Cardiovascular Disease in Patients With Sarcoidosis.Hypercalcemia, Anemia, and Acute Kidney Injury: A Rare Presentation of Sarcoidosis.Application of 'Omics' and Systems Biology to Sarcoidosis Research.Disease Burden and Variability in Sarcoidosis.Cutaneous sarcoidosis: A retrospective case series and a hospital-based case-control study in Taiwan.Increased Risk of Multimorbidity in Patients With Sarcoidosis: A Population-Based Cohort Study 1976 to 2013.Hospitalization Rates, Prevalence of Cardiovascular Manifestations, and Outcomes Associated With Sarcoidosis in the United States.High-Risk Sarcoidosis. Current Concepts and Research Imperatives.Linking Race, Cancer Outcomes, and Tissue Repair.The Burden of Comorbidity and Complexity in Sarcoidosis: Impact of Associated Chronic Diseases.Accuracy of Diagnostic Coding for Sarcoidosis in Electronic Databases: A Population-Based Study.Role of serum immunoglobulins for predicting sarcoidosis outcome: A cohort study.Sarcoidosis mortality in Sweden: a population-based cohort study.White donor, younger donor and double lung transplant are associated with better survival in sarcoidosis patients.Epidemiology of sarcoidosis: current findings and future directions
P2860
Q26748860-BC2363EC-4742-4336-8C34-74B4C79F0BC1Q28386288-B13814CE-3981-4AF0-9BDC-53734BCF47E2Q35261972-76E67D50-2945-4BB2-BB7F-2D5381B2D19FQ35554332-87910D2A-E2B8-4EBB-A4CB-8A4806B4194AQ35843553-3D4C81F7-3E57-4504-924A-4D5765148A0EQ35961291-98F92D0F-EDF1-4D90-AB1E-F68B2C01927AQ36552486-02261B65-32ED-425C-8636-D64B978F6F57Q37077481-34959C71-82B5-4AB2-B52D-49BF25A0EB3AQ37241249-35F912F1-47BD-4BC7-BE53-3066D3F0DFABQ38402783-76062A62-B3C1-452D-AD55-719DBB8DDD2EQ38641813-1E224303-C71D-4892-8710-D694014AD7C6Q38768686-3964A667-D9C9-48D8-A09E-32E34D64F650Q38773552-34E72547-AAB1-4598-B995-9D202E185DBBQ38812582-F4ED342A-A4B6-49B6-B5F6-590AF2CB1822Q38845119-97FBD238-DCB8-4CA6-A1D1-02BB1D242A4FQ39504304-CE7966AC-CE41-4DFE-B6FE-F3D19BFC148FQ39518123-B17A93B6-9ED8-430F-B556-A48B9C6B3BCDQ40089290-FC58319F-9C21-4CA5-9A56-111F5EB273E4Q40123760-2141E3FB-BC89-4DF7-B56E-0EBD21643C57Q41339241-61EE62FF-A233-42B7-A72F-A0084E3DDE00Q45070550-2F204F16-506D-4188-8658-FEB02840C711Q46218709-2F196F1C-4784-401B-AD54-02CF17F6A41AQ47138325-A7497BAA-0E75-4474-A164-2CFAD201A05BQ47647901-A7C1B045-9F8F-4D57-9BFF-44C8534251FAQ47649571-A78A40F8-F136-4EB1-97F7-5A0DF142CC8BQ47712616-179FD31B-57DA-4390-A29C-C387BB2706D9Q47839645-3F4361A3-5799-47CF-99F1-4D7778281646Q48137227-A4367FEA-C348-405A-9A29-CA9839B466F2Q48219025-D7281A3F-042D-4614-95AF-AD9C398593BEQ54974263-C8CBC472-BC93-4923-B6CF-838549986219Q55228243-63D3C8AE-C55A-4702-939E-FD2ECA618714Q55486839-4CBBBFF9-571F-4809-AF50-A37D52FA7E12Q58564538-21D220CE-A7B0-47A7-ADA8-ABF516938308
P2860
Racial difference in sarcoidosis mortality in the United States.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Racial difference in sarcoidosis mortality in the United States.
@ast
Racial difference in sarcoidosis mortality in the United States.
@en
type
label
Racial difference in sarcoidosis mortality in the United States.
@ast
Racial difference in sarcoidosis mortality in the United States.
@en
prefLabel
Racial difference in sarcoidosis mortality in the United States.
@ast
Racial difference in sarcoidosis mortality in the United States.
@en
P2093
P2860
P356
P1433
P1476
Racial difference in sarcoidosis mortality in the United States
@en
P2093
Nadera J Sweiss
Robert P Baughman
Roberto F Machado
P2860
P304
P356
10.1378/CHEST.14-1120
P407
P577
2015-02-01T00:00:00Z